erlotinib hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TARCEVA erlotinib 100 mg tablet blister pack
AUST R: 114717
Active ingredients:
erlotinib hydrochloride

Dosage form:
Tablet, film coated

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

Deletion from market:
31 Jul 2023

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products available

TARCEVA erlotinib 150 mg tablet blister pack
AUST R: 114721
Active ingredients:
erlotinib hydrochloride

Dosage form:
Tablet, film coated

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

Deletion from market:
31 Mar 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products available

TARCEVA erlotinib 25 mg tablet blister pack
AUST R: 114714
Active ingredients:
erlotinib hydrochloride

Dosage form:
Tablet, film coated

Sponsor:
Roche Products Pty Ltd

Phone:
1800233950

Deletion from market:
29 Feb 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products available